한의 성장 치료에 따른 성장 지표 변화
Change of Growth Indicators by the Treatment of Korean Medicine
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives We aimed to analyze changes in growth indicators before and after Korean medicine treatment in patients treated at the pediatric department of a hospital. Methods We analyzed the medical records of children and adolescents under 18 years of age who underwent growth assessment between January 1, 2017 and December 31, 2022. Results A total of 21 patients were selected for this study. After treatment, there was a significant increase in the height percentile, whereas bone age-chronological age (BA-CA) and predicted adult height (PAH) did not show significant changes. No major adverse reactions were observed during the treatment. Growth reassessment was conducted twice for 10 participants. When comparing the growth indicators between the assessment sessions, the height percentile showed an increasing trend between the initial and the first growth reassessment. However, there were no significant differences between BA-CA and PAH across the different assessment periods. Conclusions There is a need to establish evidence for the efficacy and safety of continuous Korean medicine growth treatment through the long-term observation of growth indicators in patients undergoing treatment for two or more periods, as well as observational studies on liver and renal function indicators.
Abstract
Objectives We aimed to analyze changes in growth indicators before and after Korean medicine treatment in patients treated at the pediatric department of a hospital. Methods We analyzed the medical records of children and adolescents under 18 years of age who underwent growth assessment between January 1, 2017 and December 31, 2022. Results A total of 21 patients were selected for this study. After treatment, there was a significant increase in the height percentile, whereas bone age-chronological age (BA-CA) and predicted adult height (PAH) did not show significant changes. No major adverse reactions were observed during the treatment. Growth reassessment was conducted twice for 10 participants. When comparing the growth indicators between the assessment sessions, the height percentile showed an increasing trend between the initial and the first growth reassessment. However, there were no significant differences between BA-CA and PAH across the different assessment periods. Conclusions There is a need to establish evidence for the efficacy and safety of continuous Korean medicine growth treatment through the long-term observation of growth indicators in patients undergoing treatment for two or more periods, as well as observational studies on liver and renal function indicators.
참고문헌 (30)
- "Statistics by ATC Codes (by In/Outpatient)" (2015)[URL]
- "Korean medicine utilization survey" (2023)[URL]
- "Korean medicine utilization survey" (2021)[URL]
- 이현희, "성장장애 한의표준임상진료지침 및 한의표준임상경로 개발을 위한 일반인의 한의치료에 대한 인식 조사", 대한한방소아과학회지, 36(1), pp.65~77 (2022), 대한한방소아과학회
- 정환희, "소아에서 성장촉진대체요법으로 사용된 한약의 예측성인신장에 대한 영향 분석", Annals of Pediatric Endocrinology & Metabolism, 13(2), pp.172~176 (2008), 대한소아내분비학회
- 김수영, "골연령 측정시 Greulich-Pyle 방법과Tanner-Whitehouse (TW3) 방법의 비교", Annals of Pediatric Endocrinology & Metabolism, 13(1), pp.50~55 (2008), 대한소아내분비학회
- 김현지, "골연령 측정을 통한 한방 성장 치료의 임상적 연구", 대한한방소아과학회지, 20(3), pp.23~32 (2006), 대한한방소아과학회
- 정민정, "한약 투여가 사춘기 전 소아의 신장성장에 미치는 영향에 대한 예비 연구", 대한한방소아과학회지, 22(3), pp.25~34 (2008), 대한한방소아과학회
- Kim YJ, "Intergrative traditional Korean medicine treatment for children with idiopathic short stature : A STROBEcompliant case series", Medicine, 101(28), pp.e29754~ (2022)
- Kang MJ, "Factors affecting bone age maturation during 3 years of growth hormone treatment in patients with idiopathic growth hormone deficiency and idiopathic short stature; analysis of date from the LG growth study", Medicine, 98(14), pp.e14962~ (2019)
- "2017Growth chart for children and youth" (2017)[URL]
- 윤혜진, "체성분 분석과 골연령 측정을 통한 취학 전 아동의 성장에 대한 임상연구", 대한한방소아과학회지, 23(2), pp.131~144 (2009), 대한한방소아과학회
- Kim SM, "The characteristic of short stature children with improved PAH by Korean herbal medicine treatment", Master, pp.2020
- e, "Assessment of skeletal maturity and prediction of adults height (TW3 Method), 3", pp.2001, Tanner JM
- 강기연, "부모의 신장과 TW3법에 의한 예측 신장 (AHP TW3)의 상관성 연구", 대한한방소아과학회지, 26(3), pp.46~54 (2012), 대한한방소아과학회[DOI]
- Department of Pediatrics, Nationwide Korean Medicine College, "Pediatrics of Korean medicine", pp.29~994 (2022), Ui Sung Dang Publishing Co
- 이혜림, "허약아와 성장지표의 상관성에 대한 연구", 대한한방소아과학회지, 28(2), pp.1~22 (2014), 대한한방소아과학회
- 박근미, "단일기관에서 전산을 통해 수집된 자발적 소아 약물유해반응 보고사례의 분석", Allergy Asthma & Respiratory Disease, 4(5), pp.354~359 (2016), 대한 소아알레르기 호흡기학회[DOI]
- Seung Chan Park, "Effects of estrogen inhibition formula herbal mixture for danazol-induced precocious puberty in female rats: an experimental study with network pharmacology", Integrative Medicine Research, 10(3), pp.1~9 (2021), 한국한의학연구원[DOI]
- 최선희, "성장 치료를 목적으로 한방병원에 내원한 환아에 대한 임상적 고찰", 대한한방소아과학회지, 32(4), pp.51~62 (2018), 대한한방소아과학회[DOI]
- 최민형, "성장에 대한 유전적·환경적 요인의 영향", 대한한방소아과학회지, 24(3), pp.138~149 (2010), 대한한방소아과학회
- 유현영, "成長補中健兒湯 투여가 소아의 신장 성장에 미치는 효과", 대한한방소아과학회지, 23(2), pp.103~115 (2009), 대한한방소아과학회
- 이혜림, "특발성 성조숙증으로 진단받은 환아 2례에 대한 증례보고", 대한한방소아과학회지, 31(1), pp.74~81 (2017), 대한한방소아과학회
- The association of Korean Oriental Pediatrics, "Childhood and adolescent growth disorder clinical practice guideline of Korean medicine", NIKOM, 22~23 (2022)
- 한지은, "소아 성장에 대한 한의학 치료: 국내 임상연구에 대한 문헌적 고찰", 대한한방소아과학회지, 35(1), pp.18~29 (2021), 대한한방소아과학회
- 공재철, "한약투여 및 식이, 운동지도를 통한 소아성장치료의 임상적 관찰", 한방재활의학과학회지, 18(3), pp.133~145 (2008), 한방재활의학과학회
- 이유진, "소아 성장을 위한 한약 투여에 대한 임상적 연구", 대한한방소아과학회지, 25(1), pp.49~62 (2011), 대한한방소아과학회
- 김지은, "소아 성장을 위한 한약 투여에 대한 후향적 연구", 대한한방소아과학회지, 30(4), pp.87~98 (2016), 대한한방소아과학회
- Kim SS, "The correlation of GH and IGF-I with the index of obesity and the change by exercise", Journal of Sport and Leisure Studies, 16, pp.271~280 (2001)
- Lee SY, "The feasibility and safety of herbal medication on short stature", Korean J Orient Int Med, 22(4), pp.513~517 (2001)